BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37790014)

  • 1. Metastatic Leptomeningeal Carcinomatosis From Primary Lobular Breast Cancer Found in a Medical School Cadaveric Dissection.
    Mitchell MC; Pollock J; Downs MB; Stephen D
    Cureus; 2023 Sep; 15(9):e44533. PubMed ID: 37790014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptomeningeal Carcinomatosis Secondary to Adenocarcinoma of the Breast: A Cadaveric Case Report.
    Damaske M; Panarese V; Casey S; Feeney M; Liuzzi FJ
    Cureus; 2021 Jan; 13(1):e12693. PubMed ID: 33604223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptomeningeal carcinomatosis in patients with breast cancer.
    Franzoi MA; Hortobagyi GN
    Crit Rev Oncol Hematol; 2019 Mar; 135():85-94. PubMed ID: 30819451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the Metronomic Biofeedback Pump for leptomeningeal carcinomatosis: technical note.
    Chen TC; Napolitano GR; Adell F; Schönthal AH; Shachar Y
    J Neurosurg; 2015 Aug; 123(2):362-72. PubMed ID: 25955873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptomeningeal Carcinomatosis: A Rare Complication of Metastatic Gastric Cancer.
    Lai SY; Bhardwaj S; Wu P
    Cureus; 2023 Jan; 15(1):e34201. PubMed ID: 36843688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis.
    Park WY; Kim HJ; Kim K; Bae SB; Lee N; Lee KT; Won JH; Park HS; Lee SC
    Cancer Res Treat; 2016 Apr; 48(2):843-7. PubMed ID: 25761487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
    Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
    Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diffuse metastatic leptomeningeal carcinomatosis (DMLC)].
    Ishikura A; Hunaki N
    Gan No Rinsho; 1987 Jul; 33(8):881-4. PubMed ID: 3613110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete response and long-term survival of leptomeningeal carcinomatosis from breast cancer with maintenance endocrine therapy.
    Almajed MM; Esfahani K; Pelmus M; Panasci L
    BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27256996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult Breast Cancer Presenting as Leptomeningeal Carcinomatosis.
    McNally ME; Carson W
    World J Oncol; 2012 Apr; 3(2):73-77. PubMed ID: 29147283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.
    Mego M; Sycova-Mila Z; Obertova J; Rajec J; Liskova S; Palacka P; Porsok S; Mardiak J
    Breast; 2011 Oct; 20(5):478-80. PubMed ID: 21700455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptomeningeal carcinomatosis and breast cancer: a systematic review of current evidence on diagnosis, treatment and prognosis.
    Mollica L; Leli C; Puglisi S; Sardi S; Sottotetti F
    Drugs Context; 2021; 10():. PubMed ID: 34745272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptomeningeal Carcinomatosis: A Case Report of Metastatic Triple-negative Breast Adenocarcinoma.
    Parker N; Forge J; Lalich D
    Cureus; 2019 Mar; 11(3):e4278. PubMed ID: 31157139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple intrathecal chemotherapy for leptomeningeal carcinomatosis in solid tumors: Treatment outcomes, response and their determinants.
    Srinivasalu VK; Subramaniam N; Philip A; Jose W; Pavithran K
    Indian J Cancer; 2021; 58(1):84-90. PubMed ID: 33402572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis.
    Chen IC; Lin CH; Jan IS; Cheng AL; Lu YS
    J Formos Med Assoc; 2016 Apr; 115(4):243-8. PubMed ID: 25890495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual case of long survival patient with leptomeningeal carcinomatosis from breast cancer.
    Pennisi G; Burattini B; Gessi M; Montano N; Perna A; Silvestri G; Papacci F
    Br J Neurosurg; 2021 Jun; ():1-4. PubMed ID: 34137319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Leptomeningeal Carcinomatosis Following Treatment of Cerebellar Metastasis of HER2+ (Human Epidermal Growth Factor Receptor 2 Positive) Breast Cancer: Case Report and Review of Literature.
    Smith PD; Bhenderu LS; Kommuri S; Fleener EE; Hoover JM
    Cureus; 2022 Apr; 14(4):e24008. PubMed ID: 35547416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database.
    Carausu M; Carton M; Darlix A; Pasquier D; Leheurteur M; Debled M; Mouret-Reynier MA; Goncalves A; Dalenc F; Verret B; Campone M; Augereau P; Ferrero JM; Levy C; Fumet JD; Lefeuvre-Plesse C; Petit T; Uwer L; Jouannaud C; Larrouquere L; Chevrot M; Courtinard C; Cabel L
    ESMO Open; 2021 Jun; 6(3):100150. PubMed ID: 33984675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leptomeningeal carcinomatosis as a rare metastatic spreading of BRAF-mutated microsatellite stable colon cancer].
    Höblinger A; Weber S; Tschirner F; Kröber S; Streetz K
    Z Gastroenterol; 2017 Jul; 55(7):667-674. PubMed ID: 28709170
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.